Cargando…
The changing landscape of the clinical value of the PM/Scl autoantibody system
Autoantibodies to the polymyositis/scleroderma (PM/Scl) complex have been associated with systemic sclerosis and PM/Scl overlap syndrome. The report of Hanke and colleagues in a recent issue of Arthritis Research and Therapy is the first to describe the separate evaluation of anti-PM/Scl-75c and PM/...
Autores principales: | Mahler, Michael, Fritzler, Marvin J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688186/ https://www.ncbi.nlm.nih.gov/pubmed/19351430 http://dx.doi.org/10.1186/ar2646 |
Ejemplares similares
-
Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen
por: Mahler, Michael, et al.
Publicado: (2005) -
Autoantibodies in Systemic Autoimmune Disorders
por: Mahler, Michael, et al.
Publicado: (2014) -
Autoantibodies directed to novel components of the PM/Scl complex, the human exosome
por: Brouwer, Rick, et al.
Publicado: (2002) -
Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients
por: Hanke, Katharina, et al.
Publicado: (2009) -
Detection of autoantibodies using chemiluminescence technologies
por: Mahler, Michael, et al.
Publicado: (2016)